Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6411 posts found.

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

May 24, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Gilead, J&J, JJ, MSD, Sandoz, pharma, top ten

On the day that UK Prime Minister Theresa May announces her resignation, we look back on the week’s biggest stories …
News
190131111631-01-shingles-vaccine-gsk-super-tease

China approves GSK’s shingles vaccine Shingrix

May 24, 2019 Medical Communications, Sales and Marketing China, GSK, Shingrix, pharma, shingles

GSK’s shingles vaccine has secured approval in China, the company said, after the National Medical Products Administration (NMPA) authorised the …
News

Mumps cases triple in England

May 24, 2019 Medical Communications MMR, UK, Vaccine, health, public health

Public Health England has urged patients to ensure that they have received the MMR vaccine after the number of cases …
News
gsk_boronia_australia

GSK to reintroduce bonuses for sales reps

May 24, 2019 Medical Communications GSK, US, oncology, pharma, sales, sales reps, scandal

British multinational GlaxoSmithKline said on Thursday that it would reintroduce performance-based bonuses for some sales reps in some countries. The …
News
medical-supplies-paper-bag

Drugmakers colluded to drive up price of anti-nausea drug by 700%

May 23, 2019 Business Services, Medical Communications Business, NHS, collusion, competition, pharma

Four pharmaceutical firms have been accused of illegally colluding to restrict the supply of anti-nausea medication Prochlorperazine after the price …
News
lilly_entrance_web

Japan’s health ministry warns of serious side effects of Lilly’s Verzenio

May 23, 2019 Business Services, Medical Communications Cancer, Eli Lilly, Verzenio, breast cancer, oncology, pharma

Japan’s Health Ministry has warned that Eli Lilly’s breast cancer therapy Verzenio could have serious side effects for patient’s lungs. …
News

GP appointments should be at least 15 minutes long by 2030, report argues

May 21, 2019 Manufacturing and Production, Medical Communications GP, NHS, UK, britain, pharma

GP consultations should be five minutes longer, with 10 minute doctors’ appointments being a ‘thing of the past,’ according to …
News
antibiotic-resistance-pill-running-from-bacteria-1500

The global rise in antibiotic resistance threatens infection prevention and cure

May 20, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antibiotic resistance, antimicrobial resistance, feature, pharma

Dr Bill Love, Founder and Chief Scientific Officer of Destiny Pharma, discusses the rise of antimicrobial resistance (AMR), the antibiotic …
Feature
roche__tree

Phase 1/2 data show Roche’s entrectinib shrinks tumours with NTRK, ROS1 or ALK gene fusions in children & adolescents

May 17, 2019 Medical Communications, Research and Development Cancer, Roche, entrectinib, pharma

Roche has unveiled new Phase 1/2 data for its selective tyrosine kinase inhibitor entrectinib, demonstrating its ability to shrink recurrent …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

May 17, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Gilead, J&J, JJ, Janssen, Mundipharma, Novartis, Teva, generics

Some big names – including Gilead, Janssen, Teva and Bristol-Myers Squibb – were in trouble this week after two separate …
News

Pfizer’s Fragmin injection secures FDA approval in paediatric symptomatic venous thromboembolism

May 17, 2019 Medical Communications, Sales and Marketing FDA, Fragmin, Pfizer, pharma

The FDA has announced its approval of Pfizer’s anticoagulant injection Fragmin (dalteparin sodium) for subcutaneous use as a treatment to …
News
46438135835_a0bd733416_z

Gilead CEO Daniel O’Day challenged over patents on PrEP drug Truvada

May 17, 2019 Medical Communications Gilead, HIV, PrEP, Truvada, patent, pharma

On 16 May, Gilead CEO Daniel O’Day was grilled over the $1,780 price tag on PrEP drug Truvada in a …
News

Twitter launches new initiative to direct users towards credible information on vaccines

May 17, 2019 Medical Communications Twitter, anti-vaccine, health, pharma, social media, vaccines

Twitter will now present users with a pinned tweet directing them towards reliable information on vaccines, according to a blog …
News
lance2

A day in the life: Lance Hill, CEO at Within3

May 17, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing A day in the life, Interview, Within3, feature

Could you give a short history of how you came to be in your current role? I’ve spent my entire …
Feature

Insider Interview: Paving paths in prostate cancer

May 16, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Interview, Janssen, feature, pharma, prostate cancer

Joaquin Casariego Garcia Luben, Medical Affairs Director Europe, Middle East & Africa, Prostate Cancer for Johnson & Johnson (pictured) discusses …
Feature
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026